Magnetar Financial LLC Alnylam Pharmaceuticals, Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $2.03 Million - $3.39 Million	-14,627 Reduced 89.26%	1,760 $352,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $1.97 Million - $2.77 Million	16,387 New	16,387 $2.39 Million
Q2 2021 Aug 06, 2021	SELL	$128.63 - $176.89 $254,687 - $350,242	-1,980 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $206,479 - $286,023	-1,628 Reduced 45.12%	1,980 $280,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $122,355 - $146,265	-995 Reduced 21.62%	3,608 $469,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $533,579 - $683,729	4,603 New	4,603 $548,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.